Drug Database
Back to search

Japan· JP-1331001F1010

ジメンヒドリナート

A dimenhydrinate product containing ジメンヒドリナート, registered in Japan, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.

On Japan’s NHI price listATC R06AA11

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedジメンヒドリナートATCR06AA11REGISTER NO.JP-1331001F1010PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ジメンヒドリナートAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dimenhydrinate is registered in 9 of 19 countries.

Countries holding a registration under ATC R06AA11 (dimenhydrinate), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 4 of them publish a price we can compare per daily dose
Search dimenhydrinate products by name

Dimenhydrinate · ATC R06AA11

9 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Franceprice
  • Germany
  • Japan
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dimenhydrinate costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Dimenhydrinate · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • US United States$0.34 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ジメンヒドリナート
Manufacturer
—
Country
Japan (JP)
ATC code
R06AA11
ATC class
Dimenhydrinate
Defined daily dose
0.3 g, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

85 interactions on record for dimenhydrinate.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dimenhydrinate against other medicinesHow interaction checks work

Dimenhydrinate · interactions on record

85 records

  • 3 severe
  • 81 moderate
  • 1 minor

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • DicycloverineA03AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under R06AA11

Dimenhydrinate, as other registers publish it.

All dimenhydrinate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b03df43a-0a13-4f35-b821-4d47d0fd3924
GET /v1/drugs/b03df43a-0a13-4f35-b821-4d47d0fd3924?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "５０ｍｇ１錠",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "1331001F1010",
  "category": "内用薬",
  "price_yen": null,
  "generic_name": "ジメンヒドリナート",
  "product_name_jp": null,
  "therapeutic_class": "1331",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about dimenhydrinate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console